Core Insights - The latest net value of Ping An Medical Health Mixed C (020137) is 2.8526 yuan, reflecting a decrease of 2.24% [1] - The fund's performance over the past month shows a return of -1.46%, ranking 4561 out of 4702 in its category; over the last six months, it has achieved a return of 72.15%, ranking 38 out of 4537; and since the beginning of the year, it has returned 84.25%, ranking 33 out of 4493 [1] Fund Holdings - The top ten stock holdings of Ping An Medical Health Mixed C account for a total of 75.91%, with the largest positions being: - Genscript Biotech (10.55%) - Innovent Biologics (9.08%) - CanSino Biologics (8.97%) - BeiGene (7.58%) - Kelun-Biotech (7.54%) - Eucure Biopharma (7.49%) - Boli Tianheng (6.34%) - Aier Eye Hospital (6.25%) - Zai Lab (6.13%) - Ascletis Pharma (5.98%) [1] Fund Manager Profile - Zhou Sicong, the fund manager, holds a master's degree in finance from Renmin University of China and has previously worked as a fund manager at Yin Hua Fund Management Co., Ltd. and Changsheng Fund Management Co., Ltd. She joined Ping An Fund Management Co., Ltd. in May 2023 [2]
8月20日平安医疗健康混合C净值下跌2.24%,近1个月累计下跌1.46%
Sou Hu Cai Jing·2025-08-20 11:51